What is the effectiveness of post-discharge pharmacotherapeutic empowerment of patients with diabetes?

Jéssica Azevedo Aquino; Thamires Natalie Souza; Cristina Sanches; Mariana Linhares Pereira; André Oliveira Baldoni

doi:10.1016/j.dsx.2019.02.002

What is the effectiveness of post-discharge pharmacotherapeutic empowerment of patients with diabetes?

Diabetes Metab Syndr. 2019 Mar-Apr;13(2):1321-1323. doi: 10.1016/j.dsx.2019.02.002. Epub 2019 Feb 5.

Authors

Jéssica Azevedo Aquino¹, Thamires Natalie Souza¹, Cristina Sanches¹, Mariana Linhares Pereira¹, André Oliveira Baldoni²

Affiliations

¹ Central-West Campus Dona Lindu, Federal University of São João del-Rei, Divinopolis, MG, Brazil; Group of Research in Epidemiology and Evaluation of New Technologies in Health, GPEANTS, UFSJ/CNPq, Brazil.
² Central-West Campus Dona Lindu, Federal University of São João del-Rei, Divinopolis, MG, Brazil; Group of Research in Epidemiology and Evaluation of New Technologies in Health, GPEANTS, UFSJ/CNPq, Brazil. Electronic address: andrebaldoni@ufsj.edu.br.

PMID: 31336485
DOI: 10.1016/j.dsx.2019.02.002

Abstract

The objective of the present article was to evaluate the glycemic control of patients with diabetes mellitus (DM) after discharge from a pharmacotherapeutic empowerment program. The results suggest that the strategy is effective for short-term glycemic control, but the benefits are not maintained after discharge, indicating the need for the pharmacist's continuous role.

MeSH terms

Adult
Diabetes Mellitus / drug therapy*
Diabetes Mellitus / psychology
Empowerment*
Female
Follow-Up Studies
Health Knowledge, Attitudes, Practice
Humans
Hyperglycemia / prevention & control*
Hypoglycemia / prevention & control*
Hypoglycemic Agents / therapeutic use*
Male
Middle Aged
Patient Discharge*
Patient Education as Topic*
Patient-Centered Care / methods
Pharmaceutical Services
Power, Psychological
Prognosis
Self Care / methods*

Substances

Hypoglycemic Agents